Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.
- NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_assertion description "[Our results suggest that the ER genomic pathway in the ER-positive and Herceptin-resistant breast cancer cells may be reactivated, allowing tamoxifen therapy to be effective again, and a combination of tamoxifen and Herceptin can be a potential therapeutic strategy for ER-positive and Herceptin-resistant human breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.
- NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_assertion evidence source_evidence_literature NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.
- NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_assertion SIO_000772 18768663 NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.
- NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_assertion wasDerivedFrom befree-2016 NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.
- NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_assertion wasGeneratedBy ECO_0000203 NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.
- befree-2016 importedOn "2016-02-19" NP691354.RAB0_FyvlM_bskDu9vVHpQWUvUfmP7kTXlCL6-MydOFi0130_provenance.